Hepatitis c assay utilizing recombinant antigens to ns1

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/18 (2006.01) C12N 9/12 (2006.01) G01N 33/576 (2006.01)

Patent

CA 2115926

2115926 9304088 PCTABS00020 The present invention provides unique recombinant antigens representing distinct antigenic regions of the NS1 region of the HCV genome which can be used as reagents for the detection of antibodies and antigen in body fluids from individuals exposed to hepatitis C virus (HCV). The present invention also provides an assay for detecting the presence of an antibody to an HCV antigen in a sample by contacting the sample with the recombinant antigens. Preferred assay formats include a screening assay, a confirmatory assay, a competition or neutralization assay and an immunodot assay.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hepatitis c assay utilizing recombinant antigens to ns1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis c assay utilizing recombinant antigens to ns1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis c assay utilizing recombinant antigens to ns1 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1403403

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.